-
-
-
-
-
-
-
Sobi to acquire Arthrosi for $950 million to expand gout treatments
-
-
-
-
-
-
-
Sobi publishes Q3 2023 report: Strong revenue and solid performance
-
-
-
-
-
-
-
Bulletin from Swedish Orphan Biovitrum (Sobi)'s Annual General Meeting (AGM)
-
-
-
-
-
-
-
Sobi Successfully Completes Acquisition of Dova Pharmaceuticals
-
-
-
-
-
-
-
Sobi Publishes Report for Second Quarter 2019
-
-
-
-
-
-
-
Sobi™ Completes Acquisition of Synagis® US Rights From AstraZeneca and Exercises Authorisation to Issue Shares
-
-
-
-
-
-
1,163,452 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

